GH

Guardant Health, Inc. develops and commercializes blood tests for cancer detection and treatment decision-making. The company focuses on precision oncology, utilizing circulating tumor DNA and biomarkers to assess treatment responses, detect residual cancer, and identify early signs of the disease. Its tests are used by healthcare providers to improve clinical outcomes for patients across various stages of cancer. Guardant Health operates primarily in the oncology sector, serving healthcare professionals and patients in the United States and internationally.